Clinical Trials Browser

Not yet recruiting × Stomach Neoplasms × Albumin-Bound Paclitaxel × Clear all

NCT07139587 2025-09-10

The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Phase NA Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT06222944 2024-01-25

Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA

Phase 2 Not yet recruiting

Gastrointestinal

Stomach Neoplasms